IGF1R and lung carcinoma: Overall, the IGF-1R signaling pathway plays a crucial role in the cellular development of anti-cancer drug resistance, and the use of IGF-1R inhibitors in conjunction with other therapies offers a promising direction for lung cancer treatment.